Pzena adds to Humana position despite Q1 detractor status

Pzena Investment Management identified Humana Inc as the largest individual detractor from performance in its first-quarter 2026 commentary for the Pzena Focused Value Strategy. The firm attributed the underperformance to a disappointing preliminary Medicare Advantage rate update proposed by the Centers for Medicare and Medicaid Services for 2027, alongside investor anxiety regarding Humana’s projected rapid membership growth and associated plan benefit designs.

Despite these headwinds, Pzena viewed the risks as timing-related rather than thesis-changing and increased its position in the insurer during the quarter’s weakness. The strategy returned -4.7 per cent net in the first quarter, underperforming the Russell 1000 Value Index, which returned 2.1 per cent. The broader equity market faced challenges during the period due to the Iran conflict and related energy price hikes, compounded by continued uncertainty surrounding artificial intelligence valuations.

Humana projected rapid growth in its Medicare Advantage membership for 2026, a move that sparked investor fears that the company’s plan benefit designs were overly rich relative to peers. Pzena noted that while the health care, financials, and technology sectors were the largest detractors from performance during the quarter, the specific concerns surrounding Humana did not alter the firm’s long-term investment view.

Data from the end of the first quarter indicates that 61 hedge fund portfolios held Humana, an increase from 53 in the previous quarter. However, the insurer was not included in Pzena’s list of the 40 most popular stocks among hedge funds heading into 2026. The firm stated that while it acknowledges the potential of Humana as an investment, it believes certain artificial intelligence stocks offer greater upside potential with less downside risk.

Humana shares closed at $360.72 on June 22, 2026, with a market capitalisation of $43.31 billion. The stock gained 51.06 per cent over the past 52 weeks as of the report date, despite the one-month return of 19.57 per cent reflecting recent volatility. Pzena maintains that the current environment presents a strong long-term opportunity for value investors, even as the fund navigated sector-specific headwinds.